Biogen (BIIB) October IV elevated
Tweet
Share
E-mail
Get Alerts BIIB Hot Sheet
Join SI Premium – FREE
Biogen (NASDAQ: BIIB) September option implied volatility is at 55, October is at 81; compared to its 52-week range 29 to 73 into topline phase 3 data for Alzheimer's drug lecanemab.
Create E-mail Alert Related Categories
OptionsRelated Entities
OptionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
